These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1399 related articles for article (PubMed ID: 25482613)

  • 1. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
    Tan EJ; Olsson AK; Moustakas A
    Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFβ and matrix-regulated epithelial to mesenchymal transition.
    Moustakas A; Heldin P
    Biochim Biophys Acta; 2014 Aug; 1840(8):2621-34. PubMed ID: 24561266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
    Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
    J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.
    Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ
    J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of EMT by TGFβ in cancer.
    Heldin CH; Vanlandewijck M; Moustakas A
    FEBS Lett; 2012 Jul; 586(14):1959-70. PubMed ID: 22710176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of epithelial-mesenchymal transition by transforming growth factor β.
    Moustakas A; Heldin CH
    Semin Cancer Biol; 2012 Oct; 22(5-6):446-54. PubMed ID: 22548724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
    Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGFβ-induced EMT in breast cancer.
    Kolliopoulos C; Lin CY; Heldin CH; Moustakas A; Heldin P
    Matrix Biol; 2019 Jul; 80():29-45. PubMed ID: 30194979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial-mesenchymal transition (EMT).
    Serrano I; McDonald PC; Lock FE; Dedhar S
    Oncogene; 2013 Jan; 32(1):50-60. PubMed ID: 22310280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer.
    Agajanian M; Runa F; Kelber JA
    Biochem Biophys Res Commun; 2015 Sep; 465(3):606-12. PubMed ID: 26297948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor β.
    Valcourt U; Carthy J; Okita Y; Alcaraz L; Kato M; Thuault S; Bartholin L; Moustakas A
    Methods Mol Biol; 2016; 1344():147-81. PubMed ID: 26520123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β.
    Tsubakihara Y; Moustakas A
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation in human melanoma: past and future.
    Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
    Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells.
    Schlegel NC; von Planta A; Widmer DS; Dummer R; Christofori G
    Exp Dermatol; 2015 Jan; 24(1):22-8. PubMed ID: 25363503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SHON, a novel secreted protein, regulates epithelial-mesenchymal transition through transforming growth factor-β signaling in human breast cancer cells.
    Li L; Liu DX; Zhang N; Liang Q; Feng J; Yao M; Liu J; Li X; Zhang Y; Lu J; Huang B
    Int J Cancer; 2015 Mar; 136(6):1285-95. PubMed ID: 25082541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells.
    Devarajan E; Song YH; Krishnappa S; Alt E
    Int J Cancer; 2012 Sep; 131(5):1023-31. PubMed ID: 22038895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal protein turnover contributes to the acquisition of TGFβ-1 induced invasive properties of mammary cancer cells.
    Kern U; Wischnewski V; Biniossek ML; Schilling O; Reinheckel T
    Mol Cancer; 2015 Feb; 14():39. PubMed ID: 25744631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoskeletal signaling in TGFβ-induced epithelial-mesenchymal transition.
    Nalluri SM; O'Connor JW; Gomez EW
    Cytoskeleton (Hoboken); 2015 Nov; 72(11):557-69. PubMed ID: 26543012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
    Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
    Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of TGFβ-induced lens epithelial to mesenchymal transition (EMT) by RTK antagonists.
    Zhao G; Wojciechowski MC; Jee S; Boros J; McAvoy JW; Lovicu FJ
    Exp Eye Res; 2015 Mar; 132():9-16. PubMed ID: 25576668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.